Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
BMC Cancer|June 22, 2023
Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancerCarolin Schimmelpfennig, Michael Rade, Susanne Füssel, et al.
British Journal of Haematology|October 30, 2009
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locusSylvia Hartmann, Stefan Gesk, René Scholtysik, et al.
British Journal of Haematology|August 14, 2019
The impact of SOCS1 mutations in diffuse large B-cell lymphomaKevin Mellert, Melanie Martin, Jochen K Lennerz, et al.
British Journal of Haematology|November 20, 2008
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphomaInga Vater, Florian Wagner, Markus Kreuz, et al.
Molecular Medicine (Cambridge, Mass.)|February 2, 2024
A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancerMichael Rade, Markus Kreuz, Angelika Borkowetz, et al.
International Journal of Cancer|June 15, 2017
TP53 mutation and survival in aggressive B cell lymphomaThorsten Zenz, Markus Kreuz, Maxi Fuge, et al.
Hemasphere|March 10, 2025
Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLAKatrin S Kurz, Sophia Steinlein, Markus Kreuz, et al.
International Journal of Cancer|June 23, 2015
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancerGunnar Wichmann, Maciej Rosolowski, Knut Krohn, et al.
Haematologica|November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphomaSietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
Nature Medicine|February 21, 2025
Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibodyTill Braun, Michael Rade, Maximilian Merz, et al.
Pageof 7